Regeneron Pharmaceuticals (REGN) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order at 10:30 A.M. in a virtual-only format to ensure shareholder participation rights, with senior officers and all directors present or connected by audio.

• The agenda and rules of conduct were posted online, and proof of mailing of proxy materials was provided with a quorum confirmed.

• Meeting included proposals for election of directors, ratification of the independent accounting firm, and an advisory vote on executive compensation.

Board and executive committee updates

• Five Class II directors were nominated for re-election for a one-year term, all currently serving on the board.

• CEO presented a strategy and business update, emphasizing innovation and leadership in biotechnology.

Shareholder proposals

• Three items were presented for shareholder vote: election of directors, ratification of the independent auditor, and an advisory vote on executive compensation.